JYNT
The Joint Corp.
NASDAQ · Healthcare · Medical - Care Facilities · US
$8.32
+0.48%Year over year
Reported trailing growth
- Revenue
- +220.6%
- EBITDA
- +1234.8%
- EBIT
- +223.3%
- EPS
- +180.1%
- Free cash flow
- +25.0%
- Operating cash flow
- +13.5%
Forward estimates
Based on analyst estimates
- Revenue
- +5.8%
- EBITDA
- +105.4%
- EPS
- +24.4%
Three-year CAGR
- Revenue
- -18.5%
- EBITDA
- -42.7%
- EBIT
- +52.1%
- Net income
- +66.8%
- EPS
- +63.7%
- Free cash flow
- -47.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026